A comparative study of circulating plasma lipid components and superoxide dismutase activity in pre and postmenopausal women
DOI:
https://doi.org/10.18203/2320-6012.ijrms20162698Keywords:
Antioxidants, Estrogen, Menopause, Oxidative stress, Superoxide dismutase, Total cholesterol, HDL-cholesterol, LDL-cholesterol, VLDL-cholesterol, TriglyceridesAbstract
Background: Menopause is associated with increased oxidative stress and decreased antioxidative activity in females which leads to increased risk of cardiovascular and many other diseases. The objective was to compare the lipid profiles and superoxide dismutase (SOD) activity of pre and postmenopausal women in an attempt to establish the fact that menopause is associated with increased oxidative stress.
Methods: A hospital based cross-sectional study was done at the department of obstetrics and gynaecology and biochemistry, Shri Mahant Indiresh Hospital, Dehradun, India. Out of total of 120 women, 60 women were in premenopausal group aged between 30-45 years and 60 women of 55-70 years of age group in post menopause status. Assessment of lipid profile was done by an automated chemistry analyzer (Vitors 5, I FS) and SOD activity was measured by colorimetric activity kit. Statistical analysis was done by Standard Microsoft Excel software.
Results: Mean serum SOD level in premenopausal women was 4.80±1.73 U/ml and in postmenopausal was 1.35±0.58 U/ml. This variation was found to be extremely significant (p <0.0001). Changes in lipid components in pre and postmenopausal women showed that total cholesterol and triglycerides levels were higher in postmenopausal than premenopausal participants. These variations were also significant (p = 0.0003). Levels of HDL-C were lower in postmenopausal women than pre-menopausal group with a mean±SD of 51.5±12.20 mg/dl and 54.05±14.03mg/dl respectively.
Conclusions: Findings of this study corroborate the hypothesis that gradual loss of ovarian function is associated with a decrease in antioxidant status. Menopause also leads to changes in lipid components, which can predispose women to cardiovascular diseases.
Metrics
References
Mishra GD, Kuh D. Health symptoms during mid-life in relation to menopausal transition: British prospective cohort study. British Med J. 2012;344:402.
Velde ER, Scheffer GJ, Dorland M, Broekmans FJ, Fauser BC. Developmental and endocrine aspects of normal ovarian aging. Molecular and cellular Endocrinology. 1998;145(1):67-73.
Ansari KU. Free radicals, their relation to diseases and pharmacologic intervention. The Indian Practitioner. 1993;46(4):261-72.
Frei B. Reactive oxygen species and antioxidant vitamins mechanisms of action. Am J Med. 1994;97(3):5-13.
Cheeseman KH, Slater TF. An introduction to free radical biochemistry. British Med Bulletin. 1993;49(3):481-93.
Ruiz LMB, Martin C, Martinez R, Nqvarro R, Lacort M, Miller NJ. Antioxidant activities of estrogens against aqueous and lipophillic radicals; differences between phenol and catechol estrogens. Chemistry and Phy Lipids. 2000;105(2):179-88.
Brezina V, Padmos I. Coronary heart disease risk factors in women. European Heart Journal. 1994;15(11):1571-84.
Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggoula AW, Wing RR. Menopause and risk factors for coronary heart disease. New England J Med. 1989;321(10):641-6.
Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 1993;98(1):83-90.
Kuller LH, Meilahn EN, Cauley JA, Gutai JP, Mathews KA. Epidemiologic studies of menopause: Changes in risk factors and disease. Experimental Gerontology. 1994;29(3):495-509.
Lobo RA. Clinical review 27 Effect of hormonal replacement on lipids and lipoproteins in post-menopausal women. Journal Clinic Endocrino Metab. 1991;73(5):925-30.
Newnham HH. 5 Oestrogens and atherosclerotic vascular disease-lipid factors. Bailliere’s Clinical Endocrinology Metabolism. 1993;7(1):61-93.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry. 1972;18(6):499-502.
Mccord JM, Fridovich I. Superoxide dismutase an enzymic function for erythrocuprein (hemocuprein). J Bio Chem. 1969;244(22):6049-55.
Hurd WW, Amesse LS, Randolph JF. Menopause. In: Jonathan SB . editor. Novek’s Gynaecology. 13th ed. Philadelphia;Lippincot Williams and Wilkins;2002:1109-42.
Aloysio D, Gambacciani M, Meschia M, Pansini F, Modena AB, Bolis PF, et al. The effect of menopause on blood lipid and lipoprotein levels. Atherosclerosis. 1999;147(1):147-53.
Medina RA, Aranda E, Verdugo C, Kato S, Owen GI. The action of ovarian hormones in cardiovascular disease. Bio Res. 2003;36(3):325-41.
Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein level as predictors of cardiovascular death in women. Archives Internal Med. 199;153(19):2209-16.
Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism. 2008;57(7):961-5.
Alfonso CC, Vez GM, García UP, Tornel OP, Canteras JM, Abellán AJ. Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women. Anales Medicina Interna. 1984;20(2):70-4.
Kannel WB. Metabolic risk factors for coronary heart disease in women perspective from the Framingham study. Am Heart J. 1987;114(2):413-9.
Gandhi BM, Raina N. Alcohol‐induced changes in lipids and lipoproteins. Alcoholism. Clinical Experimental Res. 1984;8(1):29-32.
Srivastava V, Singh S, Singh N, Sapre S. Status of antioxidant enzymes and trace metals in postmenopausal women. J Obstet Gynecol India. 2005;55(1):64-6.
Krstevska M, Dzhekova SS, Bosilkova G. Menopause, Coronary artery disease and antioxidants. Clinical Chemistry Lab Med. 2001;39(7):641-4.
Bednarek TG, Bohdanowicz PA, Bidzinska B, Milewicz A, Antonowicz JJ, Andrzeiak R. Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecological Endocrinology. 2001;15(4): 298-303.
Gurdol F, Oner YY, Yalcyn O, Genc S, Buyru F. Changes in enzymatic antioxidant defence system in blood and endometrial tissue of women after menopause. Research Communication Molecular Pathology Pharmacology. 1997;97(1):38-46.